Products & Services
Markets
Contact Us
Become a Partner
Blog
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Open Account
Sign In
Online Trading
Online Backoffice
Client Dashboard
New
Online IPO
Online Mutual Fund
E-Voting NSDL
Web Mail
Products & Services
Markets
Contact Us
Become a Partner
Blog
Reach out to us on
0120-4918900
Or
Get a call back
Click here
News Details
24/04/2025 10:46
Back
Lupin Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin Receives Approval from U. S. FDA for Tolvaptan Tablets.